Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case

Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case–control study

Published:2023-04-06 Issue:7 Volume:270 Page:3527-3536
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Sun James J.,Watkins Lance,Henley William,Laugharne Richard,Angus-Leppan Heather,Sawhney Indermeet,Shahidi Meissam Moghaddassian,Purandare Kiran,Eyeoyibo Mogbeyiteren,Scheepers Mark,Lines Geraldine,Winterhalder Robert,Perera Bhathika,Hyams Benjamin,Ashby Samantha,Shankar Rohit^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-023-11701-6.pdf

Reference40 articles.

1. Gaitatzis A, Sander JW (2004) The mortality of epilepsy revisited. Epileptic Disord 6(1):3–13

2. Puteikis K, Mameniškienė R (2021) Mortality among people with epilepsy: a retrospective nationwide analysis from 2016 to 2019. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph181910512

3. Neurology N, Network (2018) INNEoLCI. Deaths associated with neurological conditions in England 2001 to 2014. Data Analysis Report. . Public Health England

4. University, Bristol. O (2019) The Learning Disabilities Mortality Review (LeDeR) Programme, Annual Report, 2019

5. Thurman DJ, Logroscino G, Beghi E et al (2017) The burden of premature mortality of epilepsy in high-income countries: a systematic review from the Mortality Task Force of the International League Against Epilepsy. Epilepsia 58(1):17–26. https://doi.org/10.1111/epi.13604

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability;Epilepsy & Behavior;2024-09

2. Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review;Expert Review of Neurotherapeutics;2024-08-19

3. New valproate regulations, informed choice and seizure risk;Journal of Neurology;2024-06-19

4. Identifying co-morbidities and risk in people with epilepsy: The Maltese experience;Epilepsy & Behavior;2024-06

5. The relationship between clinical presentation and the nature of care in adults with intellectual disability and epilepsy – national comparative cohort study;BJPsych Open;2024-04-30